Alkermes posts fourth quarter gains, changes fiscal year
May 23, 2013 at 12:35 PM EDT
Just weeks after biopharmaceutical company Alkermes plc (Nasdaq: ALKS) released positive preliminary results of a Phase 2 clinical study of its drug to treat major depressive disorder, the Waltham, Mass...
